Kissei Pharmaceutical Co., Ltd.

4547.T
Drug Manufacturers - Specialty & Generic
2026/03/05 Updated
Market Cap: $1.2B (¥190.7B)
Stock Price: $29.16 (¥4,600)
Exchange Rate: 1 USD = ¥157.73

Notice Regarding Disposal of Treasury Stock as Restricted Stock to the Employee Stock Ownership Plan

On August 10, 2026, 504,300 shares of treasury stock will be disposed of to the employee stock ownership plan at 4,790 yen per share, totaling approximately 2,415,597,000 yen. The dilution rate is about 1.08%.

Importance:
Page Updated: February 27, 2026
IR Disclosure Date: February 27, 2026

Key Figures

  • Number of shares disposed: 504,300 shares (maximum, subject to change)
  • Disposal price: 4,790 yen per share (closing price on February 26, 2026)
  • Total disposal amount: 2,415,597,000 yen (maximum)

AI要約

Overview of Capital Policy

The Company has resolved to dispose of 504,300 shares of treasury stock as restricted stock through the Kissei Group Employee Stock Ownership Plan. The disposal price is 4,790 yen per share, totaling approximately 2,415,597,000 yen (maximum), with the payment date scheduled for August 10, 2026. This will be implemented through a scheme whereby special monetary claims are granted as incentives to eligible employees, who then contribute them to the stock ownership plan. The transfer restriction period will run from August 10, 2026, to June 2, 2031, and the transfer restrictions will be lifted under certain conditions.

Impact on Shareholders and Procedures

The dilution rate due to this treasury stock disposal will be up to 1.08% of the total shares issued and 1.22% of total voting rights. The disposal price has been reasonably calculated based on the closing price on the business day prior to the board resolution and is not a particularly advantageous price for the employee stock ownership plan, as confirmed by all auditors. Based on the regulations of the Tokyo Stock Exchange, independent third-party opinions and shareholder approval procedures are deemed unnecessary.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.